52 related articles for article (PubMed ID: 28643732)
1. Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy.
Cocomazzi G; Del Pup L; Contu V; Maggio G; Parmegiani L; Ciampaglia W; De Ruvo D; Faioli R; Maglione A; Baldini GM; Baldini D; Pazienza V
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396914
[TBL] [Abstract][Full Text] [Related]
2. Gynecological malignancies at tertiary care hospital, Pakistan: A five-year review.
Wasim T; Mushtaq J; Wasim AZ; Raana GE
Pak J Med Sci; 2021; 37(3):621-627. PubMed ID: 34104137
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Gynecological Malignancies: Focus on ASCO 2023.
Bodriagova O; Previs RA; Gaba L; Shankar A; Vidal L; Saini KS
Oncol Ther; 2023 Dec; 11(4):397-409. PubMed ID: 37715082
[No Abstract] [Full Text] [Related]
4. Primary care audit: investigating the link between thrombocytosis and gastrointestinal cancers.
Salman R
Future Healthc J; 2023 Nov; 10(Suppl 3):127. PubMed ID: 38406700
[No Abstract] [Full Text] [Related]
5. Dihydroartemisinin and its anticancer activity against endometrial carcinoma and cervical cancer: involvement of apoptosis, autophagy and transferrin receptor.
Tang T; Xia Q; Xi M
Singapore Med J; 2021 Feb; 62(2):96-103. PubMed ID: 31680182
[TBL] [Abstract][Full Text] [Related]
6. Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage.
Xu F; Li Y; Fan L; Ma J; Yu L; Yi H; Chen X; Wei W; Wu P; Liang L; Hu H; Xing H; Wang W
J Cancer; 2018; 9(9):1660-1666. PubMed ID: 29760805
[No Abstract] [Full Text] [Related]
7. Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies.
Menczer J
Arch Gynecol Obstet; 2017 Jan; 295(1):9-15. PubMed ID: 27714462
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytosis in gynecologic malignancies.
Gücer F; Tamussino K; Keil F; Balkanli-Kaplan P; Yüce MA
Anticancer Res; 2004; 24(3b):2053-9. PubMed ID: 15274400
[TBL] [Abstract][Full Text] [Related]
9. Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?
Andersen CL; Eskelund CW; Siersma VD; Felding P; Lind B; Palmblad J; Bjerrum OW; Friis S; Hasselbalch HC; de Fine Olivarius N
Gynecol Oncol; 2015 Nov; 139(2):312-8. PubMed ID: 26407478
[No Abstract] [Full Text] [Related]
10. The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor.
Kuyumcuoglu U; Guzel AI; Celik Y; Erdemoğlu M
Eur J Gynaecol Oncol; 2010; 31(5):514-6. PubMed ID: 21061791
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment thrombocytosis as a prognostic factor in women with gynecologic malignancies: a meta-analysis.
Yu M; Liu L; Zhang BL; Chen Q; Ma XL; Wu YK; Liang CS; Niu ZM; Qin X; Niu T
Asian Pac J Cancer Prev; 2012; 13(12):6077-81. PubMed ID: 23464407
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytosis in gynecological cancers.
Sharma D; Singh G
J Cancer Res Ther; 2017; 13(2):193-197. PubMed ID: 28643732
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
